Genomics through the lens of next-generation sequencing by Capra, John A et al.
Recent advances in high-throughput sequencing techno-
lo  gies  have  greatly  increased  the  scale  and  scope  of 
genomics research, and this was evident throughout the 
recent Biology of Genomes meeting at the Cold Spring 
Harbor Laboratory. Here we describe some highlights of 
the meeting.
Functional and cancer genomics
In  one  of  several  talks  that  investigated  the  causes, 
dynamics  and  phenotypic  effects  of  regulatory  change, 
Mike Snyder (Stanford University, Stanford, USA) used 
chromatin  immunoprecipitation  followed  by  DNA 
sequencing  (ChIP-seq)  to  examine  the  variability  in 
transcription factor binding among individuals in yeast 
(Saccharomyces cerevisiae) and human. In both species, 
significant  variation  was  observed,  and  the  amount  of 
binding  was  strongly  correlated  with  gene  expression. 
Much of the observed binding variation could be asso-
ciated  with  specific  single  nucleotide  polymorphisms 
(SNPs)  and  structural  changes  to  the  genome.  On  the 
basis of the patterns of variation, Snyder suggested that 
gene regulation may work like a government, with global 
regulators and local regulators all having strong effects, 
but with some focused on a more limited set of loci.
Snyder’s  talk  introduced  two  themes  that  appeared 
throughout  the  meeting:  the  widespread  adoption  of 
high-throughput sequencing as an analysis strategy; and 
a  focus  on  identifying  and  understanding  regulatory 
elements.  Axel  Visel  (Lawrence  Berkeley  National 
Labora  tory, Berkeley, USA) continued these themes in a 
talk that highlighted the limitations of using comparative 
genomics to identify enhancers. By performing ChIP-seq 
with  the  enhancer-associated  p300  protein  on  mouse 
forebrain and embryonic heart tissue, he and colleagues 
identified a large number of heart enhancers with very 
low  evolutionary  conservation  compared  to  forebrain 
enhancers. This surprising result suggests that deep path-
way  conservation  does  not  imply  regulatory  sequence 
conservation, that enhancer conservation is not predic-
tive of function, and that there are global differences in 
enhancer conservation between tissues.
Li  Ding  (Washington  University,  St  Louis,  USA) 
described  how  sequencing  samples  from  the  same 
patients at different stages of the same cancer can help 
track changes that have occurred during cancer progres-
sion,  and  possibly  lead  to  improved  drug  therapies. 
Thanks to an efficient pipeline, their genome-sequencing 
center can analyze tumor/pair samples in only 12 days. 
The  analysis  of  about  150  cancer  genomes  using  this 
pipeline  has  enabled  comparisons  of  different  cancer 
genomes from different points of view, including muta-
tion rate, mutation spectrum, copy number variation and 
structural variation. The results showed by Elaine Mardis 
(Washington University, St Louis, USA) are an example 
of how powerful these tools are and what they are able to 
achieve. She presented the analysis of the relapse genome 
of an acute myelogenous leukemia patient and a com-
pari  son  with  the  genome  sequenced  at  initial  presen-
tation.  Interestingly,  this  study  was  able  to  pinpoint 
relapse-specific mutations most likely involved in disease 
progression.
Complex trait mapping
One of the largest open issues in human genetics deals 
with  the  question  of  ‘missing  heritability’:  given  the 
generally high estimates of heritability for many complex 
traits (such as genetic susceptibility to complex diseases), 
why  have  genome-wide  association  studies  (GWAS) 
identified variants that explain only a small fraction of 
the heritable variation we know is out there? Several talks 
explored this question using a range of experimental and 
theoretical  approaches.  One  hypothesis  suggests  that 
rare  variants  of  large  effect,  which  will  generally  be 
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© 2010 BioMed Central Ltdmissed  by  GWAS,  are  a  crucial  component  of  this 
missing  variability.  Richard  Durbin  (Wellcome  Trust 
Sanger Institute, Cambridge, UK) and others described 
progress on the 1000 Genomes Project, which by next 
year  will  generate  low-coverage  (around  4x)  whole-
genome sequence data from more than 2,000 individuals. 
This dataset, in conjunction with new imputation algor-
ithms for base-calling low-coverage data, will provide a 
near-complete  catalog  of  rarer  variants  (for  example, 
minor  allele  frequency  ≥0.005)  across  the  human 
genome, which in turn will facilitate efforts to identify 
rare variants affecting disease susceptibility.
Jeffrey  Barrett  (Wellcome  Trust  Sanger  Institute, 
Cambridge, UK) addressed the subject of ‘synthetic asso-
ciations’. It has been proposed that many GWAS hits are 
not the result of common variants of modest effect, but 
rather are artifacts caused by linkage to multiple rare (but 
highly penetrant) variants. Barrett’s talk outlined several 
compelling  sources  of  evidence  suggesting  that  these 
synthetic associations are likely to be quite rare. So, while 
rare  variants  may  or  may  not  explain  the  ‘missing 
heritability’ problem, they are not a probable cause of the 
associations already discovered by GWAS.
One alternative approach to understanding the genetic 
architecture of complex traits is to use a more tractable 
genetic system. Barak Cohen (Washington University, St 
Louis,  USA)  presented  detailed  genetic  analyses  of 
sporulation efficiency in the yeast S. cerevisiae. For this 
phenotype, just four SNPs (located in three transcription 
factor  genes)  combine  to  explain  87%  of  the  total 
phenotypic variation, although very little of this (around 
25%)  could  be  ascribed  to  additive  effects.  Cohen  also 
described a thermodynamic model that might explain the 
strong  interactions  (epistasis)  observed  among  SNPs. 
This and other work raises the possibility that gene-gene 
interactions  may  be  a  large  part  of  the  answer  to  the 
missing heritability question.
Evolutionary genomics
Next-generation  sequencing  technologies  now  enable 
researchers not affiliated with genome centers to conduct 
their own genome-sequencing projects. Peter Donnelly 
(Oxford  University,  UK)  described  some  preliminary 
findings from the PanMap project, a collaborative effort 
to  sequence  and  analyze  the  genomes  of  ten  Western 
chimpanzees  (Pan  troglodytes  verus).  Donnelly  and 
colleagues were especially interested in the evolution of 
recombination  rates,  and  the  recent  fusion  between 
chimpanzee chromosomes 2a and 2b can be used as a 
‘natural experiment’ to estimate if and how chromosome 
position  influences  recombination  rate.  The  results 
suggest  that  recombination  rates  are  more  affected  by 
chromosomal position than they are by local sequence 
context.
Another  exciting  genome  project  was  described  by 
Svante  Pääbo  (Max  Planck  Institute  for  Evolutionary 
Anthropology, Leipzig, Germany). As a follow-up to the 
recent  publication  of  the  Neanderthal  genome,  Pääbo 
and colleagues have now generated roughly 2x coverage 
of the whole genome from an unclassified hominin fossil 
found in Denisova Cave in southern Siberia. Preliminary 
results suggest that the Denisova fossil is more closely 
related to Neanderthals than to modern humans, though 
the divergence between Neanderthal and the Denisova 
fossil  is  larger  than  the  divergence  between  any  two 
extant modern humans. Further studies will be needed to 
clarify  the  precise  evolutionary  relationships  between 
this fossil and other hominin groups.
New directions
Several talks gave exciting glimpses of how next-genera-
tion  sequencing  technology  can  enable  novel,  high-
throughput experimental analyses. Rob Mitra (Washing-
ton  University  School  of  Medicine,  St  Louis,  USA) 
introduced a promising new technology for investigating 
the  regulatory  networks  of  development  across  a  cell 
lineage.  By  attaching  a  transposase  to  a  transcription 
factor, Mitra forces the insertion of a transposon ‘calling 
card’ near the site of DNA-binding events. These trans-
posons, and thus binding sites, can then be identified by 
next-generation  sequencing.  As  these  trans  posons 
survive cell divisions, the binding history of a transcrip-
tion  factor  can  be  traced  though  a  cell  lineage.  The 
method has been applied successfully in yeast and tests 
are in progress in vertebrates. If successful, this approach 
would yield a powerful tool for decoding how regulation 
drives tissue-specific development.
Although  the  meeting  focused  primarily  on  humans 
and model organisms, considerable attention was given 
to the large quantities of diverse data being generated by 
the  sequencing  of  microbial  communities  through 
projects such as the Global Ocean Sampling Expedition 
and the Human Microbiome Project (HMP). Katherine 
Pollard  (Gladstone  Institutes,  University  of  California, 
San Francisco, USA) argued that traditional approaches 
to genomic analysis must be significantly adapted to take 
advantage  of  the  new  kinds  of  information  in  meta-
genomic data, which is produced by shotgun sequencing 
the  DNA  extracted  from  environmental  samples.  She 
showed  that  phylogenies  inferred  from  metagenomic 
sequence reads allow new ways of defining species, such 
as Operational Taxonomic Units (OTUs), of discovering 
novel OTUs, of defining and comparing microbial com-
mu  nity diversity, and of estimating microbial ranges in 
geographic and niche spaces.
In regard to the human microbiome, Jennifer Wortman 
(University of Maryland School of Medicine, Baltimore, 
USA)  emphasized  the  HMP’s  goal  of  discovering 
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community  composition  and  the  health  of  the  human 
host. Referencing studies of the vaginal and gut micro-
biomes, she showed that different types of communities 
require  bioinformatic  tools  with  different  levels  of 
resolution  and  specialization.  By  sequencing  the  com-
plete  genomes  of  several  closely  related  microbes 
collected from coastal ocean populations, B Jesse Shapiro 
(Massachusetts  Institute  of  Technology,  Cambridge, 
USA)  took  a  step  towards  understanding  microbial 
speciation  with  his  presentation  of  a  well-supported 
sympatric model of speciation in which populations are 
ecologically differentiated by a set of niche-specific genes.
Finally, James Taylor (Emory University, Atlanta, USA) 
offered an integrated vision of how we might aim to do 
science  in  the  age  of  next-generation  sequencing.  He 
emphasized two fundamental directions: first, increasing 
access to the ability to perform large-scale computational 
analyses;  and  second,  and  perhaps  more  important, 
ensuring  that  such  analyses  are  done  in  a  way  that 
supports  and  encourages  the  integrity  of  scientific 
investi  gation.  Taylor  demonstrated  by  an  analysis  of  a 
mitochondrial  genome  resequencing  experiment  that 
commercial cloud computing platforms can be used in 
conjunction with Galaxy, a web-based genome analysis 
tool,  to  facilitate  large-scale  analyses  that  potentially 
involve  multiple  software  programs,  while  maintaining 
the transparent provenance of the data and parameters. 
The  resulting  record  of  every  step  of  the  workflow 
guarantees that an analysis is reproducible and can be 
clearly communicated. Taylor also noted that in order to 
completely  guarantee  reproducibility,  the  original  data 
themselves  must  be  stored  permanently,  which  raises 
another challenge for this new scientific paradigm.
New  experimental  technologies  are  giving  individual 
labs  the  opportunity  to  conduct  large-scale  genomic 
studies  that  were  unimaginable  just  a  few  years  ago. 
However, the data generated on this scale present new 
challenges in interpretation, analysis and data manage-
ment. Given the quality of the science presented at this 
meeting, we are confident that the community will find 
creative and collaborative solutions for these issues.
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